(VIANEWS) – Cogent Communications Holdings (CCOI), Canadian Solar (CSIQ), Insulet (PODD) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Cogent Communications Holdings (CCOI)
84.9% sales growth and 2267.96% return on equity
Cogent Communications Holdings, Inc., through its subsidiaries, provides high-speed Internet access, private network, and data center colocation space services in North America, Europe, Asia, South America, Australia, and Africa. The company offers on-net Internet access and private network services to law firms, financial services firms, and advertising and marketing firms, as well as heath care providers, educational institutions and other professional services businesses, other Internet service providers, telephone companies, cable television companies, Web hosting companies, media service providers, mobile phone operators, content delivery network companies, and commercial content and application service providers. It also provides Internet access and private network services to customers that are not located in buildings directly connected to its network; and on-net services to customers located in buildings that are physically connected to its network. In addition, the company offers off-net services to corporate customers using other carriers' circuits to provide the last mile portion of the link from the customers' premises to the network. Further, it operates data centers that allow its customers to collocate their equipment and access the network. The company operates 54 data centers and provides facilities to 3,035 buildings and on-net services to 1,817 to multi-tenant office buildings. It serves primarily to small and medium-sized businesses, communications service providers, and other bandwidth-intensive organizations. Cogent Communications Holdings, Inc. was founded in 1999 and is headquartered in Washington, the District of Columbia.
Earnings Per Share
As for profitability, Cogent Communications Holdings has a trailing twelve months EPS of $23.64.
PE Ratio
Cogent Communications Holdings has a trailing twelve months price to earnings ratio of 2.65. Meaning, the purchaser of the share is investing $2.65 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2267.96%.
2. Canadian Solar (CSIQ)
34.5% sales growth and 18.21% return on equity
Canadian Solar Inc., together with its subsidiaries, designs, develops, manufactures, and sells solar ingots, wafers, cells, modules, and other solar power products. The company operates through two segments, Module and System Solutions (MSS), and Energy. The MSS segment engages in the design, development, manufacture, and sale of a range of solar power products, including standard solar modules, specialty solar products, and solar system kits that are a ready-to-install packages comprising inverters, racking systems, and other accessories. It also provides engineering, procurement, and construction; and operation and maintenance (O&M) services. This segment's energy solution products include solar inverters and energy storage systems for utility, commercial, residential, and specialty product applications. Its O&M services include inspections, repair, and replacement of plant equipment; and site management and administrative support services for solar power projects. The Energy segment engages in the development and sale of solar power projects; and operation of solar power plants and sale of electricity. As of January 31, 2020, this segment had a fleet of solar power plants in operation with an aggregate capacity of approximately 880.2 MWp. The company's primary customers include distributors, system integrators, project developers, and installers/EPC companies. Canadian Solar Inc. sells its products primarily under its Canadian Solar brand name; and on an OEM basis. It has operations in North America, South America, Europe, South Africa, the Middle East, Australia, Asia, and internationally. The company was founded in 2001 and is headquartered in Guelph, Canada.
Earnings Per Share
As for profitability, Canadian Solar has a trailing twelve months EPS of $5.72.
PE Ratio
Canadian Solar has a trailing twelve months price to earnings ratio of 3.9. Meaning, the purchaser of the share is investing $3.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.21%.
Sales Growth
Canadian Solar’s sales growth is 5.2% for the ongoing quarter and 34.5% for the next.
Moving Average
Canadian Solar’s value is way under its 50-day moving average of $27.28 and way under its 200-day moving average of $35.86.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Canadian Solar’s EBITDA is 23.05.
Previous days news about Canadian Solar(CSIQ)
- Canadian solar (csiq) laps the stock market: here's why. According to Zacks on Monday, 30 October, "The upcoming earnings release of Canadian Solar will be of great interest to investors. ", "On that day, Canadian Solar is projected to report earnings of $0.91 per share, which would represent a year-over-year decline of 18.75%. "
3. Insulet (PODD)
23.4% sales growth and 12.88% return on equity
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Earnings Per Share
As for profitability, Insulet has a trailing twelve months EPS of $0.9.
PE Ratio
Insulet has a trailing twelve months price to earnings ratio of 147.23. Meaning, the purchaser of the share is investing $147.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.88%.
Previous days news about Insulet(PODD)
- According to Zacks on Tuesday, 31 October, "Some better-ranked stocks from the broader medical space are Inari Medical (NARI Quick QuoteNARI – Free Report) , Insulet (PODD Quick QuotePODD – Free Report) and Cencora, Inc. (COR Quick QuoteCOR – Free Report) ."
4. Sempra Energy (SRE)
16.1% sales growth and 9.58% return on equity
Sempra operates as an energy infrastructure company in the United States and internationally. It operates through four segments: San Diego Gas & Electric Company, Southern California Gas Company, Sempra Texas Utilities, and Sempra Infrastructure. The San Diego Gas & Electric Company segment provides to San Diego and southern Orange counties; and natural gas service to San Diego County. It generates electricity through wind, solar, and other resources. As of December 31, 2022, it offered electric services to approximately 3.6 million population and natural gas services to approximately 3.3 million population that covers 4,100 square miles. The Southern California Gas Company segment owns and operates a natural gas distribution, transmission, and storage system that supplies natural gas. As of December 31, 2022, it serves a population of 21.1 million covering an area of 24,000 square miles. The Sempra Texas Utilities segment engages in the regulated electricity transmission and distribution. As of December 31, 2022, its transmission system included 18,268 circuit miles of transmission lines; 1,207 transmission and distribution substations; interconnection to 146 third-party generation facilities totaling 48,430 MW; and distribution system included approximately 3.9 million points of delivery and consisted of 123,500 miles of overhead and underground lines. The Sempra Infrastructure segment develops, builds, operates, and invests in energy infrastructure to help enable the energy transition in North American markets and worldwide. The company was formerly known as Sempra Energy and changed its name to Sempra in May 2023. Sempra was founded in 1998 and is based in San Diego, California.
Earnings Per Share
As for profitability, Sempra Energy has a trailing twelve months EPS of $3.95.
PE Ratio
Sempra Energy has a trailing twelve months price to earnings ratio of 17.69. Meaning, the purchaser of the share is investing $17.69 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.58%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 2% and a drop 5.1% for the next.
Moving Average
Sempra Energy’s value is below its 50-day moving average of $70.16 and under its 200-day moving average of $73.92.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Sempra Energy’s EBITDA is 54.5.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6%, now sitting on 16.97B for the twelve trailing months.
5. National Health Investors (NHI)
11.1% sales growth and 8.04% return on equity
Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Earnings Per Share
As for profitability, National Health Investors has a trailing twelve months EPS of $2.53.
PE Ratio
National Health Investors has a trailing twelve months price to earnings ratio of 19.53. Meaning, the purchaser of the share is investing $19.53 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.04%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 27, 2023, the estimated forward annual dividend rate is 3.6 and the estimated forward annual dividend yield is 7.29%.
Sales Growth
National Health Investors’s sales growth is 4% for the ongoing quarter and 11.1% for the next.
6. Option Care Health (OPCH)
7.2% sales growth and 17.39% return on equity
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and others; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Earnings Per Share
As for profitability, Option Care Health has a trailing twelve months EPS of $1.32.
PE Ratio
Option Care Health has a trailing twelve months price to earnings ratio of 24.35. Meaning, the purchaser of the share is investing $24.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.39%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9%, now sitting on 4.13B for the twelve trailing months.
Yearly Top and Bottom Value
Option Care Health’s stock is valued at $32.14 at 20:22 EST, way below its 52-week high of $35.87 and way higher than its 52-week low of $24.23.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 3.79%.
7. Ambev (ABEV)
5.7% sales growth and 16.92% return on equity
Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands. The company also provides carbonated soft drinks, bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices, and ready-to-drink teas under the Guaraná Antarctica, Gatorade, H2OH!, Lipton Iced Tea, Fusion, Do Bem, Pepsi-Cola, Canada Dry, Squirt, Red Rock, Red Bull, Seven Up, Nutrl, Bud Light Seltzer, Palm Bay, and Mike's brands. It offers its products through a network of third-party distributors and a direct distribution system. The company was founded in 1885 and is headquartered in São Paulo, Brazil. Ambev S.A. operates as a subsidiary of Interbrew International B.V.
Earnings Per Share
As for profitability, Ambev has a trailing twelve months EPS of $0.18.
PE Ratio
Ambev has a trailing twelve months price to earnings ratio of 13.97. Meaning, the purchaser of the share is investing $13.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.92%.
Moving Average
Ambev’s worth is under its 50-day moving average of $2.65 and under its 200-day moving average of $2.79.
Volume
Today’s last reported volume for Ambev is 9929070 which is 18.81% below its average volume of 12229600.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Dec 19, 2022, the estimated forward annual dividend rate is 0.14 and the estimated forward annual dividend yield is 5.91%.
8. Washington Federal (WAFD)
5.7% sales growth and 10.95% return on equity
Washington Federal, Inc. operates as the bank holding company for Washington Federal Bank, National Association that provides lending, depository, insurance, and other banking services in the United States. The company accepts deposit products, including business and personal checking accounts, and term certificates of deposit, as well as money market accounts and passbook savings accounts. It also provides single-family residential, construction, land acquisition and development, consumer lot, multi-family residential, commercial and industrial, commercial real estate, home equity, and consumer loans. In addition, the company offers insurance brokerage services, such as individual and business insurance policies to customers and general public; holds and markets real estate properties; mobile and internet banking services; debit and credit cards; and acts as trustee. It serves consumers, mid-sized and large businesses, and owners and developers of commercial real estate. As of September 30, 2020, the company had 234 branches located in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, and Texas. Washington Federal, Inc. was founded in 1917 and is headquartered in Seattle, Washington.
Earnings Per Share
As for profitability, Washington Federal has a trailing twelve months EPS of $4.07.
PE Ratio
Washington Federal has a trailing twelve months price to earnings ratio of 6.15. Meaning, the purchaser of the share is investing $6.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.95%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 26.7% and a negative 9.5%, respectively.
